Metraipolis › archive › dc_0e242eae2e76

Risk Stratification of Adverse Outcomes After Heart Transplantation with the 2022 Definition of Pulmonary Hypertension — Europe PMC PMID:42346447

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42346447
DOI
10.3390/jcdd13060227
License (as archived)
solo-consultazione
Archived
2026-11-01T05:48:41.286Z
SHA-256 of the archived text
31575dcd90661957d32900d3787345e74da68cf7a586eb7d8e1fa876cf5192e1
Stable URL of this page
https://metraipolis.com/documento/dc_0e242eae2e76

How to cite

Risk Stratification of Adverse Outcomes After Heart Transplantation with the 2022 Definition of Pulmonary Hypertension — Europe PMC PMID:42346447 — Europe PMC (en), https://europepmc.org/article/MED/42346447 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_0e242eae2e76 (Metraipolis archive dc_0e242eae2e76, sha256 31575dcd90661957d32900d3787345e74da68cf7a586eb7d8e1fa876cf5192e1)
BibTeX
@misc{dc0e242eae2e76,
  title = {Risk Stratification of Adverse Outcomes After Heart Transplantation with the 2022 Definition of Pulmonary Hypertension — Europe PMC PMID:42346447},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42346447},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_0e242eae2e76; sha256 31575dcd90661957d32900d3787345e74da68cf7a586eb7d8e1fa876cf5192e1},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42346447. Agents can read the archived copy with the MCP tool read_document.